Nuclear Medicine
AV45 (R+D)
Name:
AV45 (R&D)
Active Principle:
Florbetapir
Therapeutic Action:
It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. It is a supplement to other diagnostic evaluations.
Línea
Nuclear Medicine
Sublínea
PET Radiopharmaceuticals
AV45 (R+D)
Línea
Nuclear Medicine
Sublínea
PET Radiopharmaceuticals
AV45 (R+D)
Nuclear Medicine
AV45 (R+D)
Name:
AV45 (R&D)
Active Principle:
Florbetapir
Therapeutic Action:
It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. It is a supplement to other diagnostic evaluations.
RELATED PRODUCTS
-
STANNOUS CHLORIDE
STANNOUS CHLORIDEIt is indicated for: - Performing scintigraphic studies of the blood pool of the heart and great vessels. - Circulatory and placental studies. - Evaluation of gastrointestinal bleeding (especially to locate... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to...